Previous close | 4.4400 |
Open | 4.4400 |
Bid | 4.0100 x 1000 |
Ask | 4.2200 x 900 |
Day's range | 4.0600 - 4.4400 |
52-week range | 4.0600 - 106.0000 |
Volume | |
Avg. volume | 165,213 |
Market cap | 373.025M |
Beta (5Y monthly) | 2.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.0910 |
Earnings date | 21 Jun 2023 - 26 Jun 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.75 |
Key Insights The considerable ownership by individual investors in RedHill Biopharma indicates that they collectively...
Market forces rained on the parade of RedHill Biopharma Ltd. ( NASDAQ:RDHL ) shareholders today, when the covering...
RedHill Biopharma ( NASDAQ:RDHL ) Second Quarter 2022 Results Key Financial Results Revenue: US$18.3m (down 15% from 2Q...